{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:36:05Z","timestamp":1781519765152,"version":"3.54.1"},"reference-count":31,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.3892\/ijo.2016.3550","type":"journal-article","created":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T04:40:04Z","timestamp":1464756004000},"page":"639-645","source":"Crossref","is-referenced-by-count":26,"title":["Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway"],"prefix":"10.3892","volume":"49","author":[{"given":"Giuseppe","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Gigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Seguella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Nobile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"D'Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Capoccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Steardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Cuomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Sarnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,6,1]]},"reference":[{"key":"key20180107190127_b1-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/bmj.321.7264.805","article-title":"ABC of colorectal cancer: Epidemiology","volume":"321","author":"Boyle","year":"2000","journal-title":"BMJ"},{"key":"key20180107190127_b2-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0029-1242458","article-title":"Colorectal cancer epidemiology: Incidence, mortality, survival, and risk factors","volume":"22","author":"Haggar","year":"2009","journal-title":"Clin Colon Rectal Surg"},{"key":"key20180107190127_b3-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"key20180107190127_b4-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1053\/j.gastro.2008.09.064","article-title":"VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis","volume":"136","author":"Scaldaferri","year":"2009","journal-title":"Gastroenterology"},{"key":"key20180107190127_b5-ijo-49-02-0639","first-page":"334","article-title":"Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumor angiogenesis and colon cancer progression","volume":"58","author":"Ambs","year":"1998","journal-title":"Cancer Res"},{"key":"key20180107190127_b6-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1470-2045(00)00256-4","article-title":"Role of nitric oxide in carcinogenesis and tumour progression","volume":"2","author":"Lala","year":"2001","journal-title":"Lancet Oncol"},{"key":"key20180107190127_b7-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","article-title":"PI3K\/AKT\/mTOR pathway in angiogenesis","volume":"4","author":"Karar","year":"2011","journal-title":"Front Mol Neurosci"},{"key":"key20180107190127_b8-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2174\/187152012803833035","article-title":"Cancer prevention with promising natural products: Mechanisms of action and molecular targets","volume":"12","author":"Pratheeshkumar","year":"2012","journal-title":"Anticancer Agents Med Chem"},{"key":"key20180107190127_b9-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/jcp.21924","article-title":"p38 MAPK activity is stimulated by vascular endothelial growth factor receptor 2 activation and is essential for shear stress-induced angiogenesis","volume":"222","author":"Gee","year":"2010","journal-title":"J Cell Physiol"},{"key":"key20180107190127_b10-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrm1911","article-title":"VEGF receptor signalling - in control of vascular function","volume":"7","author":"Olsson","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180107190127_b11-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0002-9440(10)63876-X","article-title":"Inducible nitric oxide synthase expression in human colorectal cancer: Correlation with tumor angiogenesis","volume":"162","author":"Cianchi","year":"2003","journal-title":"Am J Pathol"},{"key":"key20180107190127_b12-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ncpgasthep1097","article-title":"Drug insight: Antiangiogenic therapies for gastrointestinal cancers - focus on monoclonal antibodies","volume":"5","author":"Reinacher-Schick","year":"2008","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"key20180107190127_b13-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.cgh.2013.12.021","article-title":"Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy","volume":"12","author":"Mullen","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20180107190127_b14-ijo-49-02-0639","first-page":"88","article-title":"New developments in traveler's diarrhea","volume":"7","author":"de la Cabada Bauche","year":"2011","journal-title":"Gastroenterol Hepatol (NY)"},{"key":"key20180107190127_b15-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ja.2014.106","article-title":"Rifaximin: Beyond the traditional antibiotic activity","volume":"67","author":"Calanni","year":"2014","journal-title":"J Antibiot (Tokyo)"},{"key":"key20180107190127_b16-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/jpet.110.170225","article-title":"Therapeutic role of rifaximin in inflammatory bowel disease: Clinical implication of human pregnane X receptor activation","volume":"335","author":"Cheng","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"key20180107190127_b17-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ejphar.2011.06.058","article-title":"Inhibition of NF-\u03baB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells","volume":"668","author":"Mencarelli","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"key20180107190127_b18-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.phrs.2010.07.001","article-title":"Characterization of PXR mediated P-glycoprotein regulation in intestinal LS174T cells","volume":"62","author":"Kota","year":"2010","journal-title":"Pharmacol Res"},{"key":"key20180107190127_b19-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"key20180107190127_b20-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1091\/mbc.E05-11-1072","article-title":"Phosphoprotein enriched in astrocytes-15 kDa expression inhibits astrocyte migration by a protein kinase C delta-dependent mechanism","volume":"17","author":"Renault-Mihara","year":"2006","journal-title":"Mol Biol Cell"},{"key":"key20180107190127_b21-ijo-49-02-0639","first-page":"3049","article-title":"Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer","volume":"29","author":"Guzi ska-Ustymowicz","year":"2009","journal-title":"Anticancer Res"},{"key":"key20180107190127_b22-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0046-8177(96)90286-5","article-title":"Growth kinetics of colorectal adenoma-carcinoma sequence: An immunohistochemical study of proliferating cell nuclear antigen expression","volume":"27","author":"Yang","year":"1996","journal-title":"Hum Pathol"},{"key":"key20180107190127_b23-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.cgh.2014.03.027","article-title":"Rifaximin is largely safe and well tolerated but caution is necessary when taken with statins","volume":"12","author":"Cacciottolo","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20180107190127_b24-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.gendis.2014.12.002","article-title":"Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas","volume":"2","author":"Cathcart","year":"2015","journal-title":"Genes Dis"},{"key":"key20180107190127_b25-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1124\/jpet.114.215913","article-title":"Activation of intestinal human pregnane X receptor protects against azoxymethane\/dextran sulfate sodium-induced colon cancer","volume":"351","author":"Cheng","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"key20180107190127_b26-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1389557515666150722105705","article-title":"Understanding the molecular mechanisms of rifaximin in the treatment of gastrointestinal disorders: A focus on the modulation of host tissue function","volume":"16","author":"Hirota","year":"2015","journal-title":"Mini Rev Med Chem"},{"key":"key20180107190127_b27-ijo-49-02-0639","first-page":"429","article-title":"Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers","volume":"3","author":"Li","year":"2009","journal-title":"Biologics"},{"key":"key20180107190127_b28-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2006.09.6305","article-title":"Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200","volume":"25","author":"Giantonio","year":"2007","journal-title":"J Clin Oncol"},{"key":"key20180107190127_b29-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1200\/JCO.2005.10.017","article-title":"Bevacizumab in combination with fluorouracil and leucovorin: An active regimen for first-line metastatic colorectal cancer","volume":"23","author":"Hurwitz","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180107190127_b30-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy","volume":"7","author":"Jain","year":"2001","journal-title":"Nat Med"},{"key":"key20180107190127_b31-ijo-49-02-0639","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1158\/0008-5472.CAN-04-1668","article-title":"Trimodal cancer treatment: Beneficial effects of combined antiangiogenesis, radiation, and chemotherapy","volume":"65","author":"Huber","year":"2005","journal-title":"Cancer Res"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2016.3550\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T14:04:55Z","timestamp":1515333895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2016.3550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,1]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,6,1]]},"published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.3892\/ijo.2016.3550"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2016.3550","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,1]]}}}